RT Book, Section
A1 Sathanandam, Shyam K.
A1 Fuller, Stephanie
A1 Gillespie, Matthew J.
A2 Gleason, Marie Murphy
A2 Rychik, Jack
A2 Shaddy, Robert
SR Print(0)
ID 56745948
T1 Chapter 5. Evaluation and Therapy: Neonatal Critical Heart Disease
T2 Pediatric Practice: Cardiology
YR 2012
FD 2012
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-176320-2
LK accesspediatrics.mhmedical.com/content.aspx?aid=56745948
RD 2024/04/24
AB Critical  heart  disease  in  the  newborn  includes  all  congenital  heart  lesions  that  would  result  in  neonatal  demise  unless  immediate  intervention  is  undertaken.  It  is  estimated  that  congenital  heart  disease  occurs  in  about  8  per  1000  live  births.1  Not  all  congenital  heart  disease  (CHD)  presents  in  the  newborn  period.  However,  there  are  a  handful  of  conditions  that  need  immediate  management  in  a  newborn  infant,  the  failure  of  which  precludes  survival.  Roughly  3.5  in  1000  live  births  have  critical  CHD.1  Neonatal  critical  heart  diseases  can  be  broadly  described  as  those  that  present  as  severe  cyanosis  (right  heart  obstruction)  and  those  that  present  as  shock  (left  heart  obstruction).  Table  5-1  lists  common  conditions  in  both  categories.  The  common  denominator  to  all  critical  heart  diseases  presenting  in  the  neonatal  period  is  that  they  need  a  patent  ductus  arteriosus  for  survival  until  further  palliative  procedures  can  be  undertaken.  To  understand  the  physiology  of  these  lesions,  it  is  important  to  have  knowledge  of  the  circulatory  changes  that  happen  right  after  birth.